CILP-2 Antibodies

Santa Cruz Biotechnology delivers a wide array of CILP-2 monoclonal antibodies for investigating CILP-2 in various biological processes. CILP-2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CILP-2, or Cartilage Intermediate Layer Protein 2, is a key extracellular matrix protein that plays a significant role in cartilage development and maintenance. CILP-2 influences chondrocyte function and has been linked to various musculoskeletal disorders. Research focused on CILP-2 continues to reveal important insights about cartilage biology. Understanding CILP-2 function may lead to breakthroughs in treating joint diseases. Investigating CILP-2 expression patterns can provide valuable information about cartilage development. Studying CILP-2 interactions with other matrix proteins helps explain cartilage structure and function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of cartilage biology and potential therapeutic approaches.